Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 1,320 | 1,535 | 1,416 | 1,422 | 724 |
| Operating Income | -1,320 | -1,535 | -1,416 | -1,422 | -724 |
| Interest Expense | 0 | 1 | 7 | 10 | 15 |
| Other Income | -2,104 | 1,207 | 0 | 0 | 0 |
| Pre-tax Income | -3,424 | -329 | -1,423 | -1,432 | -739 |
| Net Income Continuous | -3,424 | -329 | -1,423 | -1,432 | -739 |
| Net Income | $-3,424 | $-329 | $-1,423 | $-1,432 | $-739 |
| EPS Basic Total Ops | -427.20 | -44.97 | -337.26 | -269.81 | -179.87 |
| EPS Basic Continuous Ops | -430.96 | -50.70 | -321.83 | -278.06 | -187.22 |
| EPS Diluted Total Ops | -427.20 | -44.97 | -337.26 | -269.81 | -179.87 |
| EPS Diluted Continuous Ops | -430.96 | -50.70 | -321.83 | -278.06 | -187.22 |
| EBITDA(a) | $-1,316 | $-1,531 | $-1,412 | $-1,421 | $-724 |